Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Vetter Implements New Serialization Services

Mar 28, 2014

Vetter launches new serialization process to support track-and-trace efforts.

Regulatory Compliance Associates Expands into Poland

Mar 28, 2014

RCA opens a new office in Warsaw, Poland.

AmerisourceBergen Acquires Minority Interest in Profarma

Mar 28, 2014

AmerisourceBergen to establish a joint venture for specialty distribution with Profarma.

Crystal PharmaTech Collaborates with Freeslate for Solid Form Screening

Mar 26, 2014

Crystal Pharmatech selects Freeslate for its CM Protege PharmD System.

Catalent Increases Investment in Redwood Bioscience

Mar 25, 2014

Catalent increases its minority investment in Redwood Bioscience for engineering ADCs.

FDA approves Novartis' Xolair for Rare Skin Disease

Mar 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

FDA Approves Eliquis to Reduce the Risk of Blood Clots

Mar 18, 2014

FDA approves Eliquis (apixaban) for DVT and PE in patients who have undergone hip or knee replacement surgery.

Charles River Laboratories to Acquire the CRO Services Division of Galapagos NV

Mar 18, 2014

Charles River Laboratories to acquire CROs Argenta and BioFocus.

Catalent To Present at INTERPHEX

Mar 17, 2014

Catalent will recognize 80 years of softgel advancements with presentations at INTERPHEX.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here